Live Breaking News & Updates on Theseus Pharmaceuticals Inc|Page 5
Stay updated with breaking news from Theseus pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Theseus Pharmaceuticals Inc THRX on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price… ....
CAMBRIDGE, Mass., Dec. 22, 2023 /PRNewswire/ Theseus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery,. ....
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Theseus Pharmaceuticals, Inc. to Concentra Biosciences, LLC for between $3.90 and $4.05 in cash is fair to Theseus. ....
Biopharmaceutical company Theseus Pharmaceuticals, Inc. (THRX) announced Friday it has entered into a definitive merger agreement whereby Concentra Biosciences, LLC will acquire Theseus for a price per share of Theseus common stock of between $3. ....
Theseus Pharmaceuticals Inc (NASDAQ: THRX) on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price per share of between $3.90 and $4.05 in cash, consisting of a base cash price of $3.90 per share and an addi ....